Announcements Trials

Browse Landscape

Phase

Phase 1 4 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

OTHER 64 NIH 21 INDUSTRY 10 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 55 Carcinoma, Non-Small-Cell Lung 33 Stomach Neoplasms 28 Colorectal Neoplasms 26 Small Cell Lung Carcinoma 19 Lung Neoplasms 18 Rectal Neoplasms 16 Pancreatic Neoplasms 14 Neoplasms 14 Neoplasm Metastasis 14 Uterine Cervical Neoplasms 12 Esophageal Neoplasms 12 Ovarian Neoplasms 11 Nasopharyngeal Carcinoma 11 Carcinoma, Hepatocellular 11 Recurrence 10 Leukemia, Myeloid, Acute 10 Melanoma 9 Esophageal Squamous Cell Carcinoma 8 Colonic Neoplasms 8 Triple Negative Breast Neoplasms 7 Lymphoma, Non-Hodgkin 7 Head and Neck Neoplasms 7 Hodgkin Disease 6 Cholangiocarcinoma 6 Adenocarcinoma of Lung 6 Squamous Cell Carcinoma of Head and Neck 5 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms, Germ Cell and Embryonal 5

Interventions

pembrolizumab 1 entinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Uveal Melanoma × Clear all

NCT02697630 2023-12-08

PEMDAC

Vastra Gotaland Region

Phase 2 Completed

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡